Tagomics
Cambridge, United Kingdom · Founded 2021 · $8.5M raised
- Headquarters
- Cambridge
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- tagomics.com
- Total Funding
- $8.5M
- Last Round
- $8.5M Series AFeb 2024
- Rounds
- 1
About
Tagomics is a Cambridge-based biotechnology company founded in 2021 as a University of Birmingham spinout, working to transform disease diagnosis through comprehensive multiomic profiling. The company combines genomics and a proprietary epigenetics technology to create cell-free DNA (cfDNA)-based multi-omic biomarkers for early cancer detection and precision medicine. Co-founded by Dr. Jack Kennefick (CEO) and Dr. Robert Neely (CSO), Tagomics partners with companies such as Agilent Technologies to advance its platform.
Summary
Tagomics is a Biotech company based in Cambridge, United Kingdom, founded in 2021. It has raised $8.5M in total across 1 round, most recently a $8.5M Series A round in Feb 2024. Investors include Calculus Capital, Illumina Ventures and Agilent Ventures.
Funding History
Feb 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tagomics"><img src="https://indexed.vc/api/badge/company/tagomics" alt="Tagomics on Indexed.vc" width="260" height="76" /></a>